When I was diagnosed with peritoneal mesothelioma at 21 years old, the doctors gave me 18 months to live; that was 18 years ...

About one in six men with grade group 1 prostate cancer have higher-risk disease, showing outcomes vary and biopsy grade may ...

Keytruda and Padcev generated promising topline results for those with muscle-invasive bladder cancer who are ineligible for ...

I’m a testicular cancer survivor diagnosed at 20. My story is about finding strength, building routines, and sharing hope for ...

Among Janus kinase (JAK) inhibitor-naïve patients with myelofibrosis, treatment with the combination of pelabresib and ...

Childhood cancer treatments can accelerate biological aging which increases survivors’ risk for long-term health issues like ...

Dr. Aaron Gerds explained when treatment with rusfertide will become accessible for patients with a myeloproliferative neoplasm like polycythemia vera.

The FDA accepted vepdegestrant’s new drug application for ER+/HER2–, ESR1-mutated advanced breast cancer with a June 5, 2026, ...

A nurse with metastatic breast cancer praised biology-guided radiation for her slow-growing squamous cell cancer and the team's thoughtful care.

Panelists highlight advances in myeloma treatment, focusing on innovative T cell therapies like CAR T and T cell engagers, ...

I was facing rare mesothelioma alone at 21 years old, but sharing my story connected me to a community that offers hope and ...

A diverticulitis concern led to a prostate cancer diagnosis that shifted a patient's mindset and highlighted the importance ...